Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
-
Shares outstanding
-
264,351,875
-
Total 13F shares
-
29,690,135
-
Share change
-
+20,297,042
-
Total reported value
-
$112,309,052
-
Put/Call ratio
-
169%
-
Price per share
-
$3.78
-
Number of holders
-
42
-
Value change
-
+$77,501,715
-
Number of buys
-
31
-
Number of sells
-
16
Institutional Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q3 2025
As of 30 Sep 2025,
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,690,135 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, HHLR ADVISORS, LTD., ADAGE CAPITAL PARTNERS GP, L.L.C., MORGAN STANLEY, Ariose Capital Management Ltd, Exome Asset Management LLC, Siren, L.L.C., Candriam S.C.A., Woodline Partners LP, and Point72 Hong Kong Ltd.
This page lists
42
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.